CPT code 20526 denotes a therapeutic injection into the carpal tunnel to provide short-term symptom relief for carpal tunnel syndrome (CTS), a common entrapment neuropathy of the median nerve. This procedure is widely used as a nonoperative, symptomatic treatment option across outpatient settings. Nationally, the code matters because it captures a frequently billed, low-complexity intervention with implications for ambulatory care utilization and short-term symptom management strategies.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for when and where the procedure is performed, typical sites of service, and the role of the injection in CTS care pathways. The publication also summarizes benchmarking topics and policy-relevant items readers should expect: national utilization benchmarks, coding and billing considerations for outpatient injection services, and payer coverage patterns where available.

This executive summary equips clinicians, billing professionals, and policy analysts with a clear understanding of what CPT code 20526 represents, why it is relevant to ambulatory musculoskeletal care, and the practical framing for further review of reimbursement, utilization, and documentation guidance. Data not available in the input is noted where applicable in detailed sections.